Milton C. Ault III - Dec 22, 2023 Form 4 Insider Report for Alzamend Neuro, Inc. (ALZN)

Role
10%+ Owner
Signature
/s/ Milton C. Ault, III
Stock symbol
ALZN
Transactions as of
Dec 22, 2023
Transactions value $
$635
Form type
4
Date filed
12/27/2023, 04:30 PM
Previous filing
Mar 11, 2024
Next filing
Jan 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALZN Common Stock Purchase $185 +200 +0.12% $0.92 167K Dec 22, 2023 Direct
transaction ALZN Common Stock Purchase $450 +500 +1.96% $0.90 26K Dec 26, 2023 By Ault Alpha LP F1
holding ALZN Common Stock 737K Dec 22, 2023 By Ault Lending, LLC F2
holding ALZN Common Stock 996K Dec 22, 2023 By Ault Life Sciences, Inc. F3
holding ALZN Common Stock 667K Dec 22, 2023 By Ault Life Sciences Fund, LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Milton C. Ault, III, is the Manager of Ault Alpha GP LLC ("Ault GP") and Ault Capital Management LLC ("AC Management"). Ault GP and AC Management are the general partner and investment manager to Ault Alpha LP, respectively. As such, Mr. Ault is deemed to beneficially own the shares held by Ault Alpha LP.
F2 Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of Ault Alliance, Inc. ("AAI"). Mr. Ault, the Executive Chairman of AAI, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
F3 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
F4 Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.